David J Petillo, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Grossman Dr, Braintree, MA 02184 Phone: 781-849-1000 |
Lindsey Christine Burghardt, MD Emergency Medicine - Pediatric Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 340 Wood Rd, Suite 310, Braintree, MA 02184 Phone: 781-356-6200 |
Dr. Mark P Dematteo, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Grossman Dr, Braintree, MA 02184 Phone: 781-849-1000 |
News Archive
UNICEF expects children to be among the worst affected by the devastating 7.9 earthquake that struck Nepal today, affecting the area around the capital city of Kathmandu. While the full impact of the disaster is still being assessed, an estimated 40 percent of Nepal's population is children, who are the most vulnerable during emergencies.
Findings about what specific components of diets are most beneficial are frequently changing. However, an ongoing study of older adults shows evidence that one type of diet can help mitigate cognitive problems. An ongoing prospective study called the Chicago Health and Aging Project has shown that adherence to the Mediterranean diet can reduce the risk of cognitive decline with older age.
The eyes of nocturnal mammals have very large numbers of highly-sensitive rod photoreceptors (the cell type responsible for night vision).
The Cetaphil® brand, the #1 dermatologist-recommended brand of cleansers and moisturizers announced the launch of Cetaphil® Restoraderm® products, formulated specifically for the needs of eczema and atopic dermatitis skin. Cetaphil® Restoraderm® Skin Restoring Body Wash and Skin Restoring Moisturizer soothes itching associated with skin affected by eczema and atopic dermatitis.
Orthovita, Inc. , an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Vitoss Bioactive Foam-2X Bone Graft Substitute for use as a non-structural bone void filler for use in the spine, pelvis and extremities. Orthovita expects to launch the newest addition to its bone graft substitute product line by late February or early March of 2011.
› Verified 6 days ago